Skip to content
  • Print

Genentech Fellowship | Clinical Science – Non-Oncology Early Clinical Development

Genentech Logo gRED's OMNI Early Clinical Development (Genentech Research and Early Development) organization is responsible for developing and executing early development clinical strategies in healthy volunteers and patients to provide data for gRED non-oncology new molecular entities with respect to safety, tolerability, efficacy, pharmacokinetics, pharmacodynamics and the utility of biomarkers. This two-year Clinical Science fellowship provides in-depth exposure to Early Clinical Development and understanding the basic principles of Clinical Research. The fellow will function as a Clinical Scientist and will support Medical Directors/senior-level Clinical Scientists on a diverse set of clinical development activities. Learn more about Genentech.

Fellows will spend 90% of their time on duties specific to the industry site and 10% of time on professional development activities with the Thomas J. Long School of Pharmacy. All fellows will be eligible for adjunct faculty status.

Activities at Genentech

The fellow will function as a clinical scientist and will support medical directors/senior level clinical scientists on the following activities:

  • Serve as a clinical science representative on cross-functional sub-teams (i.e. protocol execution, clinical, biomarkers, pharmacokinetics)
  • Create, review and present clinical slides for internal (i.e. Genentech/Roche) and external meetings (e.g. Investigator meetings, scientific congresses, advisory boards, site visits, site staff training)
  • Develop understanding of Good Clinical Practice (GCP), International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), FDA, EMA, NICE and other relevant guidelines and regulations
  • Draft abstracts, posters, manuscripts for scientific meetings
  • Author and review of clinical documents (i.e. clinical trial protocols, clarifications and amendments, informed consents, investigator brochures, clinical study reports, investigational new drug submissions)
  • Respond to inquiries from health authorities (e.g. FDA, EMA) and study site ethics committees
  • Partner with data management team to assist with the development of case report forms
  • Serve as a primary point of contact for study inquiries
  • Contribute to ongoing review of the integrity of clinical trial data
  • Develop understanding of Phase I-II drug development

Fellowship Program Dates

The fellowship begins on July 1, 2020 and ends on June 30, 2022.

Fellowship Eligibility Requirements

A candidate must be:

  • A permanent resident or citizen of the United States
  • PharmD from an accredited college or university before the start of the fellowship term

Application Process

Candidates must submit all the following application materials by e-mail ( by the deadline listed below:

  • Letter of intent
  • Updated curriculum vitae (CV)
  • Three (3) letters of recommendation emailed directly from letter writer to FIP Director
  • One professional writing sample
  • Unofficial pharmacy school transcript emailed to FIP Director
  • Applications directed to:

Sachin A. Shah, PharmD, FAHA
Director, Fellowship in Industry Program
3601 Pacific Ave, Stockton, CA 95211

Application Deadline

December 13, 2019. Application materials must be received by 11:59pm PST

ASHP Midyear Clinical Meeting Personnel Placement Service
Participation in the Personnel Placement Service (PPS) at the ASHP Midyear Clinical Meeting is strongly encouraged, but not required. Request an interview and submit the following through the PPS portal or by e-mail to Sachin A. Shah at

  • Letter of intent
  • Curriculum Vitae (CV)

Download button iconDownload the Fellowship in Industry Program Brochure

For more information, please contact:
Sachin A. Shah, PharmD, FAHA
Fellowship in Industry Program Director
Professor of Pharmacy Practice
University of the Pacific
Thomas J. Long School of Pharmacy
3601 Pacific Avenue, Stockton, CA 95211 | 707.423.3277